CME
Diabetic Eye Disease Pipeline Therapies Part 1: Faricimab, KSI-301, and OPT-302
Host: Christina Y. Weng, MD, MBA Guest: David Eichenbaum, MD This discussion with Program Chair Christina Y. Weng, MD, MBA, and David A Eichenbaum, MD, includes a case study that highlights challenges with managing diabetic eye disease durin